Canton Strategic Holdings (CNTN) Revenue & Revenue Breakdown
Canton Strategic Holdings Revenue Highlights
0
Latest Revenue (Q)
$1.50M
Canton Strategic Holdings Revenue by Period
Canton Strategic Holdings Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Canton Strategic Holdings generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Canton Strategic Holdings Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $1.50M | 100.00% |
| 2026-03-31 | - | 100.00% |
| 2025-12-31 | - | 100.00% |
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Canton Strategic Holdings generated $1.50M in revenue during Q2 2026, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Canton Strategic Holdings Revenue Breakdown
Canton Strategic Holdings Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 26 |
|---|---|
| Other Revenue | $1.30M |
Latest
Canton Strategic Holdings's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Other Revenue (100.00%).
Canton Strategic Holdings Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics | $178.03M | $7.29M |
| ANL | Adlai Nortye | $5.00M | $2.50M |
| BLRX | BioLineRx | $4.80M | $6.86M |
| ADTX | Aditxt | $3.19M | $12.16K |
| ICU | SeaStar Medical | $1.23M | $615.00K |
| GOVX | GeoVax Labs | - | - |
| APLM | Apollomics | - | - |
| AIMD | Ainos | - | $152.00 |
| CNTN | Canton Strategic | - | $1.50M |
| MBRX | Moleculin Biotech | - | - |
| LNAI | Lunai Bioworks | - | - |